CN Patent

CN106659761A — 初级癌症疗法后使用的含硼蛋白酶体抑制剂

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2017-05-10 · 9y expired

What this patent protects

本公开涉及包括式(I)的蛋白酶体抑制剂或其药学上可接受的盐的方法或给药方案， 所述方法或给药方案用于治疗癌症或预防癌症复发或进展，其中环A、Z 1 和Z 2 如本文所定义。

USPTO Abstract

本公开涉及包括式(I)的蛋白酶体抑制剂或其药学上可接受的盐的方法或给药方案， 所述方法或给药方案用于治疗癌症或预防癌症复发或进展，其中环A、Z 1 和Z 2 如本文所定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN106659761A
Jurisdiction
CN
Classification
—
Expires
2017-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.